Company Filing History:
3 out of 446 
2 out of 2 Years Active: 2021-2024
Title: Thomas Ebensen: Innovator in Hepatitis C Research
Introduction
Thomas Ebensen is a notable inventor based in Braunschweig, Germany. He has made significant contributions to the field of immunology, particularly in the development of vaccines for hepatitis C virus (HCV). With a total of 3 patents, his work has the potential to impact public health positively.
Latest Patents
Ebensen's latest patents focus on immunogenic compositions for hepatitis C virus. These compositions include hepatitis C virus (HCV) E1E2 heterodimers, HCV E2, or HCV E1, combined with an adjuvant such as a cyclic dinucleotide or an archaeosome. The methods disclosed aim to induce an immune response in individuals against HCV by administering an effective amount of these immunogenic compositions.
Career Highlights
Throughout his career, Thomas Ebensen has worked with prestigious institutions, including the University of Alberta and the Helmholtz Center for Infection Research. His research has been pivotal in advancing the understanding and treatment of hepatitis C.
Collaborations
Ebensen has collaborated with esteemed colleagues, including Michael Houghton and Abdolamir Landi, further enhancing the impact of his research in the scientific community.
Conclusion
Thomas Ebensen's innovative work in hepatitis C research exemplifies the importance of scientific inquiry in addressing global health challenges. His contributions through patents and collaborations continue to pave the way for advancements in immunology.